Effectiveness of Helicobacter pylori eradication in chronic urticaria: Evidence-based analysis using the Grading of Recommendations Assessment, Development, and Evaluation system

Current Opinion in Allergy and Clinical Immunology

Volumn 10, Issue 4, 2010, Pages 362-369

  Shakouri, Ali ^a   Compalati, Enrico ^b   Lang, David M ^c   Khan, David A ^d  

^a Los Colinas Medical Center   (United States)

^b UNIVERSITY OF GENOA   (Italy)

^c LERNER RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

and Evaluation approach; chronic urticaria; Development; evidence based; Grading of Recommendations Assessment; Helicobacter pylori

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE; ANTIINFECTIVE AGENT;

CHRONIC URTICARIA; CLINICAL TRIAL; EVIDENCE BASED MEDICINE; GASTROINTESTINAL DISEASE; GRADING OF RECOMMENDATION ASSESSMENT DEVELOPMENT AND EVALUATION SYSTEM; HELICOBACTER INFECTION; HUMAN; MEDICAL ASSESSMENT; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; PUBLICATION; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME; CHRONIC DISEASE; CLINICAL TRIAL (TOPIC); COMPLICATION; DRUG EFFECTS; HEALTH CARE PLANNING; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; PRACTICE GUIDELINE; PROCEDURES; URTICARIA;

ANTI-BACTERIAL AGENTS; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; EVIDENCE-BASED MEDICINE; HEALTH PLANNING GUIDELINES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME; URTICARIA;

EID: 77954660809     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32833c79d7     Document Type: Review

References (39)

1. Pounder RE, Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther 1995; 9 (Suppl 2):33-39.
2. Torres J, Leal-Herrera Y, Perez-Perez G, et al. A community-based seroepidemiologic study of Helicobacter pylori infection in Mexico. J Infect Dis 1998; 178:1089.
3. Smoak BL, Kelley PW, Taylor DN. Seroprevalence of Helicobacter pylori infections in a cohort of US Army recruits. Am J Epidemiol 1994; 139:513-519.
4. Everhart JE, Kruszon-Moran D, Perez-Perez GI, et al. Seroprevalence and ethnic differences in Helicobacter pylori infection among adults in the United States. J Infect Dis 2000; 181:1359-1363.
5. Parsonnet J. The Incidence of Helicobacter pylori infection. Aliment Pharmacol Ther 1995; 9 (Suppl 2):45-51.
6. Bayerdörffer E, Neubauer A, Rudolph B, et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995; 345:1591-1594.
7. Wedi B, Kapp A. Helicobacter pylori infection in skin diseases: a critical appraisal. Am J Clin Dermatol 2002; 3:273-282. (Pubitemid 34615390)
8. Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections. Allergy Asthma Clin Immunol 2009; 5:10.
9. Federman DG, Kirsner RS, Moriarty JP, Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J Am Acad Dermatol 2003; 49:861-864.
10. Moreira A, Rodrigues J, Delgado L, et al. Is Helicobacter pylori infection associated with chronic idiopathic urticaria? Allergol Immunopathol (Madr) 2003; 31:209-214.
11. Schünemann H. Integrative assessment of evidence in healthcare: the GRADE system. Z Evid Fortbild Qual Gesundhwes 2009; 103:261-268.
12. Brozek JL, Akl EA, Alonso-Coello P, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy 2009; 64:669-677.
13. Brozek JL, Akl EA, Jaeschke R, Lang DM, et al.Grading quality of evidence and strength of recommendations in clinical practice guidelines: Part 2 of 3. The GRADE approach to grading quality of evidence about diagnostic tests and strategies. Allergy 2009; 64:1109-1116.
14. Atkins D, Eccles M, Flottorp S, et al. Systems for grading the quality of evidence and the strength of recommendations I: critical appraisal of existing approaches. The GRADE Working Group. BMC Health Serv Res 2004; 4:38.
15. Atkins D, Best D, Briss PA, et al. Grading quality of evidence and strength of recommendations. BMJ 2004; 328:1490.
16. Gaig P, García-Ortega P, Enrique E, et al. Efficacy of the eradication of Helicobacter pylori infection in patients with chronic urticaria: a placebocontrolled double blind study. Allergol Immunopathol (Madr) 2002; 30:255-258.
17. Tebbe B, Geilen CC, Schulzke JD, et al. Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol 1996; 34:685-686.
18. Wedi B, Kapp A. Helicobacter pylori infection and skin diseases. J Physiol Pharmacol 1999; 50:753-776.
19. Di Campli C, Gasbarrini A, Nucera E, et al. Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria. Dig Dis Sci 1998; 43:1226-1229. (Pubitemid 28272556)
20. Bonamigo RR, Leite CS, Bakos L. Association of Helicobacter pylori and chronic idiopathic urticaria. Rev Assoc Med Bras 1999; 45:9-14.
21. Fukuda S, Shimoyama T, Umegaki N, et al. Effect of Helicobacter pylori eradication in the treatment of Japanese patients with chronic idiopathic urticaria. J Gastroenterol 2004; 39:827-830. (Pubitemid 39409662)
22. Magen E, Mishal J, Schlesinger M, Scharf S. Eradication of Helicobacter pylori infection equally improves chronic urticaria with positive and negative autologous serum skin test. Helicobacter 2007; 12:567-571.
23. Yadav MK, Rishi JP, Nijawan S. Chronic urticaria and Helicobacter pylori. Indian J Med Sci 2008; 62:157-162.
24. Abdou AG, Elshayeb EI, Farag AG, Elnaidany NF. Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies. Int J Dermatol 2009; 48:464-469.
25. Sakurane M, Shiotani A, Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. J Dermatol 2002; 29:23-27.
26. Schnyder B, Helbling A, Pichler WJ. Chronic idiopathic urticaria: natural course and association with Helicobacter pylori infection. Int Arch Allergy Immunol 1999; 119:60-63.
27. Ozkaya-Bayazit E, Demir K, Ozgüroglu E, et al. Helicobacter pylori eradication in patients with chronic urticaria. Arch Dermatol 1998; 134:1165-1166.
28. Valsecchi R, Pigatto P. Chronic urticaria and Helicobacter pylori. Acta Derm Venereol 1998; 78:440-442.
29. Wustlich S, Brehler R, Luger TA, et al. Helicobacter pylori as a possible bacterial focus of chronic urticaria. Dermatology 1999; 198:130-132.
30. Daudén E, Jimé nez-Alonso I, García-Díez A. Helicobacter pylori and idiopathic chronic urticaria. Int J Dermatol 2000; 39:446-452.
31. Hook-Nikanne J, Varjonen E, Harvima RJ, Kosunen TU. Is Helicobacter pylori infection associated with chronic urticaria? Acta Derm Venereol 2000; 80:425-426.
32. Erel F, Sener O, Erdil A, et al. Impact of Helicobacter pylori and Giardia lamblia infections on chronic urticaria. J Investig Allergol Clin Immunol 2000; 10:94-97.
33. Hellmig S, Troch K, Ott SJ, et al. Role of Helicobacter pylori Infection in the treatment and outcome of chronic urticaria. Helicobacter 2008; 13:341-345.
34. Garza-Gonzalez E, Bosques-Padilla FJ, Tijerina-Menchaca R, et al. Comparison of endoscopy-based and serum-based methods for the diagnosis of Helicobacter pylori. Can J Gastroenterol 2003; 17:101-106.
35. Ricci C, Holton J, Vaira D. Diagnosis of Helicobacter pylori: invasive and noninvasive tests. Best Pract Res Clin Gastroenterol 2007; 21:299-313.
36. McColl K. Helicobacter pylori infection. N Engl J Med 2010; 362:1597-1604.
37. Blaser MJ. Who are we? Indigenous microbes and the ecology of human diseases. EMBO Rep 2006; 7:956-960.
38. Blaser MJ, Chen Y, Reibman J. Does Helicobacter pylori protect against asthma and allergy? Gut 2008; 57:561-567.
39. Chen Y, Blaser MJ. Helicobacter pylori colonization is inversely associated with childhood asthma. J Infect Dis 2008; 198:553-560.